Efficacy and safety of daptomycin: systematic review and meta-analysis.

Ther Adv Infect Dis · 2019 · PMC7005973 · PMID 32082568

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A nonsignificant trend for less risk of therapeutic failures of daptomycin in patients with cSSI, endocarditis, or bacteremia was demonstrated in the clinical trials included in this meta-analysis, especially for those caused by S. aureus.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.